~~<i id='3724A84CA8'><strike id='3724A84CA8'><tt id='3724A84CA8'><pre id='3724A84CA8'></pre></tt></strike></i>~~

Home» knowledge» leisure time

leisure time

author：focus 2025-10-02 01:36:04 Page View：35537

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Suspect in Ukraine detonates explosives at a courthouse, killing himself and wounding 2 officers
Next article： Walensky prepares to leave CDC — and Congress — behind

explore

Affirmative action in medical school literally saved lives

AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

1 in 4 Americans hadn't contracted COVID by the end of 2022, CDC estimates

0:53Shoppers,somewearingmasks,visitinamarket,July14,2022inLosAngeles,duringtheCOVID-19pandemic.LosAn

Moonlake's readout produced a cash windfall. Risks remain

MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

Ph.D. graduate surprised with gift registry: 'You deserve to be celebrated'

2:40DanielleGreenegraduatedinJunewithadoctorateineducationfromStanfordUniversity.CourtesyofDanielleG